GAMMA Investing LLC Raises Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

GAMMA Investing LLC increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 155.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,357 shares of the medical instruments supplier’s stock after purchasing an additional 3,869 shares during the period. GAMMA Investing LLC’s holdings in DENTSPLY SIRONA were worth $121,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in XRAY. JPMorgan Chase & Co. grew its position in DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the period. Synovus Financial Corp acquired a new stake in DENTSPLY SIRONA during the third quarter worth about $240,000. Tidal Investments LLC purchased a new position in DENTSPLY SIRONA during the third quarter valued at approximately $602,000. Wilmington Savings Fund Society FSB acquired a new position in DENTSPLY SIRONA in the third quarter valued at approximately $261,000. Finally, M&T Bank Corp lifted its holdings in DENTSPLY SIRONA by 5.6% in the third quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier’s stock valued at $1,058,000 after acquiring an additional 2,062 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Robert W. Baird cut their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC dropped their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $27.27.

View Our Latest Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $18.85 on Friday. The stock has a 50 day moving average of $19.36 and a two-hundred day moving average of $23.18. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60. The firm has a market cap of $3.75 billion, a P/E ratio of -9.11, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the previous year, the business earned $0.49 earnings per share. The firm’s revenue for the quarter was up .4% on a year-over-year basis. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.40%. DENTSPLY SIRONA’s payout ratio is presently -30.92%.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.